Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Longevity Venture Partners is an early-stage venture capital fund founded by Stephen Rosedale and Ronald Wilheim, based in Israel. The firm focuses on investing in the Silvertech, Healthcare, and Wellness sectors, targeting four to six companies annually. Their mission centers on improving the quality and longevity of the older population.
This firm invests in early-stage companies within the Silvertech, Healthcare, and Wellness sectors, aiming to enhance independence among the aging population. They collaborate with corporate investors like CommuniCare to create a commercial ecosystem that supports portfolio companies in testing and refining their value propositions for the U.S. market.
Submit your pitch through their form at longevityventurepartners.com.
Yes, Longevity Venture Partners typically leads investment rounds in the companies they back, providing both capital and strategic guidance.
The firm is open to follow-on investments, particularly for companies that demonstrate strong growth potential and alignment with their mission.
Specific fund size details are not disclosed, but the firm invests in four to six companies each year at early stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.